US FDA Publishes Draft Guidance for Industry Regarding Cannabis and Cannabis-derived Compounds
In July 2020, the US Food and Drug Administration (FDA) published the draft guidance entitled Cannabis and Cannabis Derived Compounds: Quality Considerations for Cli...